Cara Therapeutics Inc
(NAS:CARA)
$
0.348
0.0046 (1.34%)
Market Cap: 19.09 Mil
Enterprise Value: -30.04 Mil
PE Ratio: 0
PB Ratio: 1.63
GF Score: 45/100 Cara Therapeutics Inc (CARA) Transcripts
- Q4 2023 Cara Therapeutics Inc Earnings Call TranscriptMar 04, 2024$0.9998 (+5.24%)Earnings
- Cara Therapeutics Inc Corporate Update Call TranscriptJan 22, 2024
- Q3 2023 Cara Therapeutics Inc Earnings Call TranscriptNov 13, 2023$1.18 (+12.38%)Earnings
- Cara Therapeutics Inc at Canaccord Genuity Growth Conference TranscriptAug 09, 2023
- Q2 2023 Cara Therapeutics Inc Earnings Call TranscriptAug 07, 2023$2.95 (-5.75%)Earnings
- Cara Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 Cara Therapeutics Inc Earnings Call TranscriptMay 15, 2023$4.15 (+3.75%)Earnings
- Cara Therapeutics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Q4 2022 Cara Therapeutics Inc Earnings Call TranscriptMar 06, 2023$10.02 (-2.53%)Earnings
- Cara Therapeutics Inc Capital Markets Day TranscriptFeb 16, 2023
- Cara Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Cara Therapeutics Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Q3 2022 Cara Therapeutics Inc Earnings Call TranscriptNov 07, 2022$9.34 (+1.74%)Earnings
- Cara Therapeutics Inc Virtual NP Day TranscriptSep 20, 2022
- Q2 2022 Cara Therapeutics Inc Earnings Call TranscriptAug 08, 2022$11.5 (+2.04%)Earnings
- Cara Therapeutics Inc to Discuss KOMFORT Phase 2 Topline Data - Conference Call TranscriptJun 30, 2022
- Cara Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Cara Therapeutics Inc Earnings Call TranscriptMay 09, 2022$7.45 (-7.34%)Earnings
- Cara Therapeutics Inc Research And Development Event (Virtual) TranscriptMar 11, 2022
- Q4 2021 Cara Therapeutics Inc Earnings Call TranscriptMar 01, 2022$10.06 (-2.99%)Earnings
- Cara Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Cara Therapeutics Inc Earnings Call TranscriptNov 08, 2021$17.23 (-3.69%)Earnings
- Cara Therapeutics Inc KORSUVAâ„¢ Injection Approval Conference Call TranscriptAug 23, 2021
- Q2 2021 Cara Therapeutics Inc Earnings Call TranscriptAug 09, 2021$12.51 (-2.11%)Earnings
- Cara Therapeutics Inc Annual Shareholders Meeting TranscriptJun 03, 2021
- Cara Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Cara Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Cara Therapeutics Inc Earnings Call TranscriptMay 10, 2021$12.38 (-1.43%)Earnings
- Cara Therapeutics Inc Presenting Therapeutics KARE Phase 2 Topline Data -Corporate Call TranscriptApr 29, 2021
- Cara Therapeutics Inc R&D Day TranscriptApr 07, 2021
- Q4 2020 Cara Therapeutics Inc Earnings Call TranscriptFeb 25, 2021$19.26 (-2.83%)Earnings
- Cara Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Cara Therapeutics Inc Earnings Call TranscriptNov 09, 2020$14.51 (+4.01%)Earnings
- Cara Therapeutics Inc to Discuss the US License Agreement for I.V. Korsuva with Vifor Pharma PLC Call TranscriptOct 20, 2020
- Q2 2020 Cara Therapeutics Inc Earnings Call TranscriptAug 10, 2020$17.22 (+1.59%)Earnings
- Cara Therapeutics Inc Annual Shareholders Meeting TranscriptJun 04, 2020
- Cara Therapeutics Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 Cara Therapeutics Inc Earnings Call TranscriptMay 11, 2020$15.78 (+11.36%)Earnings
- Cara Therapeutics, Inc. - Special Call TranscriptApr 21, 2020
- Q4 2019 Cara Therapeutics Inc Earnings Call TranscriptFeb 27, 2020$15.35 (-3.22%)Earnings
- Cara Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Cara Therapeutics, Inc. - Special Call TranscriptDec 03, 2019
- Q3 2019 Cara Therapeutics Inc Earnings Call TranscriptNov 05, 2019$20.74 (+1.77%)Earnings
- Q2 2019 Cara Therapeutics Inc Earnings Call TranscriptAug 07, 2019$22.63 (+1.85%)Earnings
- Cara Therapeutics, Inc. - KALM-1 Pivotal Phase 3 Trial of KORSUVAâ„¢ Injection in Hemodialysis Patients with Pruritus Call TranscriptMay 29, 2019
- Cara Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 16, 2019
- Q1 2019 Cara Therapeutics Inc Earnings Call TranscriptMay 07, 2019$19 (-5.71%)Earnings
- Q4 2018 Cara Therapeutics Inc Earnings Call TranscriptMar 12, 2019$17.43 (+1.75%)Earnings
- 1